Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

84.71
+0.60000.71%
Post-market: 84.740.0300+0.04%19:57 EDT
Volume:10.06M
Turnover:851.40M
Market Cap:212.71B
PE:12.31
High:85.22
Open:84.16
Low:83.84
Close:84.11
Loading ...

Merck & Co. Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
18 Jul

Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business

Motley Fool
·
17 Jul

Johnson & Johnson's stock surges as tariff cost estimate slashed and profit outlook raised

Dow Jones
·
16 Jul

The market's been wrong on the Fed for three straight years - this Deutsche Bank strategist says it's now looking like four.

Dow Jones
·
16 Jul

Dow's 267-Point Fall Led By Losses In American Express, UnitedHealth Stocks

Dow Jones
·
15 Jul

Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA

GlobeNewswire
·
15 Jul

Merck Stock (MRK) Bulls Cheer $10Bn Verona Pharma Gamble

TIPRANKS
·
15 Jul

Jefferies Sticks to Its Buy Rating for Merck & Company (MRK)

TIPRANKS
·
14 Jul

BRIEF-Merck & Co Advances Mk-8527 Pre-Exposure Prophylaxis (Prep) Clinical Trials Globally

Reuters
·
14 Jul

Merck & Co. Inc. Announces Phase 3 Trials for Once-Monthly HIV Prevention Pill MK-8527 in Collaboration with Gates Foundation

Reuters
·
14 Jul

Biotech Stocks Are Ready to Rebound. 3 to Watch Now. -- Barrons.com

Dow Jones
·
14 Jul

Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs. -- Heard on the Street -- WSJ

Dow Jones
·
13 Jul

FDA May Fast Track Drug Reviews for Lower US Prices, Bloomberg Reports

MT Newswires Live
·
11 Jul

2 Top Stocks Down 16% and 17% This Year to Buy and Hold

Motley Fool
·
11 Jul

FDA Approves Merck's BRAVECTO QUANTUM: A Year-Long Flea and Tick Protection for Dogs

Reuters
·
11 Jul

UBS Sticks to Their Buy Rating for Merck & Company (MRK)

TIPRANKS
·
11 Jul

BRIEF-FDA Approves Bravecto Quantum, a Long-Acting Injectable for Dogs 6 Months and Older

Reuters
·
10 Jul

Morgan Stanley Adjusts Price Target on Merck to $98 From $99, Maintains Equalweight Rating

MT Newswires Live
·
10 Jul

Merck price target lowered to $98 from $99 at Morgan Stanley

TIPRANKS
·
10 Jul

Big Pharma on the Clock as 200% Tariffs Loom

GuruFocus.com
·
10 Jul